$HEB News Wednesday's biggest gaining and decl
Post# of 74551
Posted On: 07/13/2014 1:02:51 PM
$HEB News
Wednesday's biggest gaining and declining stocks 6:03 p.m. Dec. 2, 2009 - MarketWatch
Dyax, Santarus, CytRx soar; Hemispherx craters 12:38 p.m. Dec. 2, 2009 - Val Brickates Kennedy
Stocks in focus for Wednesday 7:47 p.m. Dec. 1, 2009 - MarketWatch
Ford tips higher, Santarus surges in late session 7:37 p.m. Dec. 1, 2009 - Laura Mandaro
Hemispherx Biopharma shares sink 44% after hours 6:29 p.m. Dec. 1, 2009 - Laura Mandaro
Oops: I have to eat crow over these stupid picks 9:55 a.m. June 19, 2009 - Chuck Jaffe
Vaccine makers get boost from flu scare 1:20 p.m. May 21, 2009 - Val Brickates Kennedy
Hemispherx leads drug stocks lower 1:29 p.m. May 19, 2009 - Val Brickates Kennedy
Dr. Reddy's, Hemispherx lead drug stocks 1:24 p.m. May 18, 2009 - Val Brickates Kennedy
Pigs will get slaughtered on swine-flu stocks 6:27 p.m. April 30, 2009 - Chuck Jaffe
Shares of antiviral drugmakers rocket on flu news 1:54 p.m. April 27, 2009 - Val Brickates Kennedy
Niche antiviral drugmakers rocket on flu news 10:08 a.m. April 27, 2009 - Val Brickates Kennedy
Hemispherx started at mkt outperform: Boenning & Scattergood 3:47 p.m. Dec. 4, 2006 - Tomi Kilgore
Tuesday's biggest stock gainers and decliners 6:21 p.m. Aug. 29, 2006 - Michael Baron
Short sellers dwindle as multiple forces aim to thwart strategy 11:51 a.m. June 14, 2006 - Alistair Barr
Highlights of rising and falling U.S. stocks 4:58 p.m. May 24, 2006 - MarketWatch
Bird-flu concerns knock airlines, Asian currencies 4:52 p.m. May 24, 2006 - Steve Goldstein
Drug stocks mixed, bird-flu drugmakers rally 4:51 p.m. May 24, 2006 - Val Brickates Kennedy
Hemisherx BioPharma up 10% at $2.95 9:39 a.m. May 24, 2006 - Tomi Kilgore
Drug stocks end mixed; Serono dives on sale plan 4:40 p.m. April 10, 2006 - Val Brickates Kennedy
10-K: HEMISPHERX BIOPHARMA INC 4:06 p.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: HEMISPHERX BIOPHARMA INC 5:06 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: HEMISPHERX BIOPHARMA INC 4:15 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotechs Ramping Up On China's Avian Flu Outbreak 2:42 a.m. April 8, 2013 - Seeking Alpha
Biotech Movers: A Doubler for Opexa 3:30 a.m. Feb. 11, 2013 - InvestorPlace.com
2 Biotech Stocks That Could Be Prime Candidates For The Short Seller 12:18 p.m. Dec. 21, 2012 - Seeking Alpha
Panel Rejects Drug for Chronic Fatigue Syndrome 7:52 p.m. Dec. 20, 2012 - The Wall Street Journal Interactive Edition
Amgen Licenses ImmunoGen Tech, Hemispherx Drug Questioned by FDA: Healthcare Business Recap 4:25 p.m. Dec. 19, 2012 - Wall St. Cheat Sheet
Stock Watch Wednesday, 19 December 10:24 a.m. Dec. 19, 2012 - Seeking Alpha
Hemispherx Faces FDA Day 7:51 a.m. Dec. 19, 2012 - Seeking Alpha
FDA Questions Hemispherx's Fatigue Drug 6:12 p.m. Dec. 18, 2012 - The Wall Street Journal Interactive Edition
Strong Small Cap Biopharma Catalyst Trades And Investments For Consideration 8:55 a.m. Dec. 18, 2012 - Seeking Alpha
Hemispherx's Ampligen Is Unlikely To Receive FDA Approval 6:46 a.m. Dec. 18, 2012 - Seeking Alpha
Potential Drug for Fatigue to Get New Review 11:21 p.m. Dec. 16, 2012 - The Wall Street Journal Interactive Edition
Ampligen: The Political Calculus Has Changed 6:37 a.m. Dec. 12, 2012 - Seeking Alpha
Tuesday's Small-Cap Biopharma Catalyst Trade List 9:45 a.m. Dec. 11, 2012 - Seeking Alpha
Hemispherx's Ampligen For The Treatment Of Chronic Fatigue Syndrome: A Regulatory Conundrum 5:52 a.m. Dec. 9, 2012 - Seeking Alpha
Hemispherx Biopharma: A Voice Of Reason Amid The Din 8:34 a.m. Dec. 4, 2012 - Seeking Alpha
3 Stocks With High Alphas: Acadia, Hemispherx, And Vringo 10:50 a.m. Nov. 8, 2012 - Seeking Alpha
Savient Pharmaceuticals May Continue To Run Higher 1:10 p.m. Oct. 9, 2012 - Seeking Alpha
Hemispherx Biopharma and Bioclones Join Forces in Effort to Eradicate HIV/AIDS Virus Based on Recent Clinical Insights of Wistar Institute, University of Pennsylvania 8:31 a.m. July 8, 2014 - GlobeNewswire
Hemispherx Biopharma to Present During the 2014 BIO International Convention June 26 8:30 a.m. June 25, 2014 - GlobeNewswire
Hemispherx Announces New Publication With Potential Insight Into High Mortality Rate in Middle Eastern Respiratory Syndrome (MERS) 8:31 a.m. June 16, 2014 - GlobeNewswire
Hemispherx Announces That the University of Texas Medical Branch Confirms Activity of Alferon(R) N Against MERS (Middle East Respiratory Syndrome) Virus 1:08 p.m. June 3, 2014 - GlobeNewswire
Hemispherx Receives New U.S. Composition of Matter Patent Covering Ampligen(R) Formulations 9:28 a.m. May 27, 2014 - GlobeNewswire
Hemispherx and GP Pharm Agree to Establish a Manufacturing Operation in Argentina to Serve Latin America Markets and Ancillary Markets 8:31 a.m. May 21, 2014 - GlobeNewswire
Hemispherx Biopharma Formally Collaborates With the Swiss Department of Defense, Civil Protection and Sports to Study Alferon(R) Against Tamiflu Resistant Influenza Virus Strains 8:31 a.m. May 14, 2014 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2014 4:16 p.m. May 9, 2014 - GlobeNewswire
Technical Recap on Biotech Equities -- Research on Hemispherx Biopharma, Orexigen Therapeutics, Dynavax Technologies, and Synergy Pharma 2:30 p.m. May 8, 2014 - PR Newswire - PRF
Alferon(R) N Effective Against MERS (Middle East Respiratory Syndrome) Virus In-Vitro 8:32 a.m. May 5, 2014 - GlobeNewswire
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma 1:20 p.m. April 8, 2014 - PR Newswire - PRF
Hemispherx Biopharma Announces New Publication Enlarges the Understanding of Ampligen(R) Safety Profile Across Diverse Animal Species and Focuses on the Unique TLR-3 Receptor/Ampligen(R) Interaction 8:31 a.m. April 8, 2014 - GlobeNewswire
Hemispherx Biopharma, Inc. Presented Clinical Interpretations on CFS Treatment at the 11th Biennial International Research and Clinical Conference 8:33 a.m. March 24, 2014 - GlobeNewswire
Momentum Indicators for Health Care Equities -- Research on Arena Pharma, Hemispherx Biopharma, PDL BioPharma and Celgene 8:16 a.m. March 20, 2014 - PR Newswire - PRF
Hemispherx Biopharma, Inc. to Present Clinical Interpretations on CFS Treatment at the 11th Biennial International Research and Clinical Conference 8:30 a.m. March 19, 2014 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2013 8:30 a.m. March 14, 2014 - GlobeNewswire
Hemispherx Biopharma Announces Plans to File for Regulatory Approval of Ampligen(R) to Treat Chronic Fatigue Syndrome (CFS) in Three Additional Latin America Countries 11:01 a.m. March 10, 2014 - GlobeNewswire
Hemispherx Biopharma Wins Federal Lawsuit Regarding Investment Banking Fees 8:30 a.m. March 10, 2014 - GlobeNewswire
Hemispherx Biopharma Publishes Full National Press Club Presentation on Corporate Website 9:30 a.m. Feb. 24, 2014 - GlobeNewswire
Hemispherx Biopharma Summarizes Clinical Results Presented in Washington, DC on January 30, 2014 in Conjunction with the American Society for Microbiology (ASM) Biodefense Conference Aimed at Developing a Universal Influenza Vaccine to Prevent Pandemic Influenza Threat 11:48 p.m. Feb. 4, 2014 - GlobeNewswire
Wednesday's biggest gaining and declining stocks 6:03 p.m. Dec. 2, 2009 - MarketWatch
Dyax, Santarus, CytRx soar; Hemispherx craters 12:38 p.m. Dec. 2, 2009 - Val Brickates Kennedy
Stocks in focus for Wednesday 7:47 p.m. Dec. 1, 2009 - MarketWatch
Ford tips higher, Santarus surges in late session 7:37 p.m. Dec. 1, 2009 - Laura Mandaro
Hemispherx Biopharma shares sink 44% after hours 6:29 p.m. Dec. 1, 2009 - Laura Mandaro
Oops: I have to eat crow over these stupid picks 9:55 a.m. June 19, 2009 - Chuck Jaffe
Vaccine makers get boost from flu scare 1:20 p.m. May 21, 2009 - Val Brickates Kennedy
Hemispherx leads drug stocks lower 1:29 p.m. May 19, 2009 - Val Brickates Kennedy
Dr. Reddy's, Hemispherx lead drug stocks 1:24 p.m. May 18, 2009 - Val Brickates Kennedy
Pigs will get slaughtered on swine-flu stocks 6:27 p.m. April 30, 2009 - Chuck Jaffe
Shares of antiviral drugmakers rocket on flu news 1:54 p.m. April 27, 2009 - Val Brickates Kennedy
Niche antiviral drugmakers rocket on flu news 10:08 a.m. April 27, 2009 - Val Brickates Kennedy
Hemispherx started at mkt outperform: Boenning & Scattergood 3:47 p.m. Dec. 4, 2006 - Tomi Kilgore
Tuesday's biggest stock gainers and decliners 6:21 p.m. Aug. 29, 2006 - Michael Baron
Short sellers dwindle as multiple forces aim to thwart strategy 11:51 a.m. June 14, 2006 - Alistair Barr
Highlights of rising and falling U.S. stocks 4:58 p.m. May 24, 2006 - MarketWatch
Bird-flu concerns knock airlines, Asian currencies 4:52 p.m. May 24, 2006 - Steve Goldstein
Drug stocks mixed, bird-flu drugmakers rally 4:51 p.m. May 24, 2006 - Val Brickates Kennedy
Hemisherx BioPharma up 10% at $2.95 9:39 a.m. May 24, 2006 - Tomi Kilgore
Drug stocks end mixed; Serono dives on sale plan 4:40 p.m. April 10, 2006 - Val Brickates Kennedy
10-K: HEMISPHERX BIOPHARMA INC 4:06 p.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: HEMISPHERX BIOPHARMA INC 5:06 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: HEMISPHERX BIOPHARMA INC 4:15 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotechs Ramping Up On China's Avian Flu Outbreak 2:42 a.m. April 8, 2013 - Seeking Alpha
Biotech Movers: A Doubler for Opexa 3:30 a.m. Feb. 11, 2013 - InvestorPlace.com
2 Biotech Stocks That Could Be Prime Candidates For The Short Seller 12:18 p.m. Dec. 21, 2012 - Seeking Alpha
Panel Rejects Drug for Chronic Fatigue Syndrome 7:52 p.m. Dec. 20, 2012 - The Wall Street Journal Interactive Edition
Amgen Licenses ImmunoGen Tech, Hemispherx Drug Questioned by FDA: Healthcare Business Recap 4:25 p.m. Dec. 19, 2012 - Wall St. Cheat Sheet
Stock Watch Wednesday, 19 December 10:24 a.m. Dec. 19, 2012 - Seeking Alpha
Hemispherx Faces FDA Day 7:51 a.m. Dec. 19, 2012 - Seeking Alpha
FDA Questions Hemispherx's Fatigue Drug 6:12 p.m. Dec. 18, 2012 - The Wall Street Journal Interactive Edition
Strong Small Cap Biopharma Catalyst Trades And Investments For Consideration 8:55 a.m. Dec. 18, 2012 - Seeking Alpha
Hemispherx's Ampligen Is Unlikely To Receive FDA Approval 6:46 a.m. Dec. 18, 2012 - Seeking Alpha
Potential Drug for Fatigue to Get New Review 11:21 p.m. Dec. 16, 2012 - The Wall Street Journal Interactive Edition
Ampligen: The Political Calculus Has Changed 6:37 a.m. Dec. 12, 2012 - Seeking Alpha
Tuesday's Small-Cap Biopharma Catalyst Trade List 9:45 a.m. Dec. 11, 2012 - Seeking Alpha
Hemispherx's Ampligen For The Treatment Of Chronic Fatigue Syndrome: A Regulatory Conundrum 5:52 a.m. Dec. 9, 2012 - Seeking Alpha
Hemispherx Biopharma: A Voice Of Reason Amid The Din 8:34 a.m. Dec. 4, 2012 - Seeking Alpha
3 Stocks With High Alphas: Acadia, Hemispherx, And Vringo 10:50 a.m. Nov. 8, 2012 - Seeking Alpha
Savient Pharmaceuticals May Continue To Run Higher 1:10 p.m. Oct. 9, 2012 - Seeking Alpha
Hemispherx Biopharma and Bioclones Join Forces in Effort to Eradicate HIV/AIDS Virus Based on Recent Clinical Insights of Wistar Institute, University of Pennsylvania 8:31 a.m. July 8, 2014 - GlobeNewswire
Hemispherx Biopharma to Present During the 2014 BIO International Convention June 26 8:30 a.m. June 25, 2014 - GlobeNewswire
Hemispherx Announces New Publication With Potential Insight Into High Mortality Rate in Middle Eastern Respiratory Syndrome (MERS) 8:31 a.m. June 16, 2014 - GlobeNewswire
Hemispherx Announces That the University of Texas Medical Branch Confirms Activity of Alferon(R) N Against MERS (Middle East Respiratory Syndrome) Virus 1:08 p.m. June 3, 2014 - GlobeNewswire
Hemispherx Receives New U.S. Composition of Matter Patent Covering Ampligen(R) Formulations 9:28 a.m. May 27, 2014 - GlobeNewswire
Hemispherx and GP Pharm Agree to Establish a Manufacturing Operation in Argentina to Serve Latin America Markets and Ancillary Markets 8:31 a.m. May 21, 2014 - GlobeNewswire
Hemispherx Biopharma Formally Collaborates With the Swiss Department of Defense, Civil Protection and Sports to Study Alferon(R) Against Tamiflu Resistant Influenza Virus Strains 8:31 a.m. May 14, 2014 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2014 4:16 p.m. May 9, 2014 - GlobeNewswire
Technical Recap on Biotech Equities -- Research on Hemispherx Biopharma, Orexigen Therapeutics, Dynavax Technologies, and Synergy Pharma 2:30 p.m. May 8, 2014 - PR Newswire - PRF
Alferon(R) N Effective Against MERS (Middle East Respiratory Syndrome) Virus In-Vitro 8:32 a.m. May 5, 2014 - GlobeNewswire
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma 1:20 p.m. April 8, 2014 - PR Newswire - PRF
Hemispherx Biopharma Announces New Publication Enlarges the Understanding of Ampligen(R) Safety Profile Across Diverse Animal Species and Focuses on the Unique TLR-3 Receptor/Ampligen(R) Interaction 8:31 a.m. April 8, 2014 - GlobeNewswire
Hemispherx Biopharma, Inc. Presented Clinical Interpretations on CFS Treatment at the 11th Biennial International Research and Clinical Conference 8:33 a.m. March 24, 2014 - GlobeNewswire
Momentum Indicators for Health Care Equities -- Research on Arena Pharma, Hemispherx Biopharma, PDL BioPharma and Celgene 8:16 a.m. March 20, 2014 - PR Newswire - PRF
Hemispherx Biopharma, Inc. to Present Clinical Interpretations on CFS Treatment at the 11th Biennial International Research and Clinical Conference 8:30 a.m. March 19, 2014 - GlobeNewswire
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2013 8:30 a.m. March 14, 2014 - GlobeNewswire
Hemispherx Biopharma Announces Plans to File for Regulatory Approval of Ampligen(R) to Treat Chronic Fatigue Syndrome (CFS) in Three Additional Latin America Countries 11:01 a.m. March 10, 2014 - GlobeNewswire
Hemispherx Biopharma Wins Federal Lawsuit Regarding Investment Banking Fees 8:30 a.m. March 10, 2014 - GlobeNewswire
Hemispherx Biopharma Publishes Full National Press Club Presentation on Corporate Website 9:30 a.m. Feb. 24, 2014 - GlobeNewswire
Hemispherx Biopharma Summarizes Clinical Results Presented in Washington, DC on January 30, 2014 in Conjunction with the American Society for Microbiology (ASM) Biodefense Conference Aimed at Developing a Universal Influenza Vaccine to Prevent Pandemic Influenza Threat 11:48 p.m. Feb. 4, 2014 - GlobeNewswire
(0)
(0)